Pre-Implantation Genetic Diagnosis
Fertility Treatment
Pre-Implantation Genetic Diagnosis
What is Pre-Implantation Genetic Diagnosis?
Pre-Implantation Genetic Diagnosis (PGD) is an IVF technique used to screen embryos for genetic disorders before implantation. By analyzing the embryo’s genetic material, PGD helps identify inherited conditions such as cystic fibrosis or Down syndrome. This process ensures that only healthy embryos are implanted, reducing the risk of genetic diseases and increasing the chances of a healthy pregnancy.
How is the procedure performed?
Pre-Implantation Genetic Diagnosis (PGD) involves:
Egg retrieval and fertilization to create embryos.
Culturing embryos for 3-5 days until they reach the blastocyst stage.
Removing a few cells for genetic testing.
Analyzing cells for genetic disorders or abnormalities.
Selecting healthy embryos for implantation.
Transferring healthy embryos to the uterus for a better chance of pregnancy.
- ALL SERVICES
- HYSTEROSCOPIC SEPTUM RESECTION
- HYSTEROSCOPIC ADHESIOLYSIS
- HYSTEROSCOPIC POLYPECTOMY
- HYSTEROSCOPIC TUBAL CANNULATION
- DONOR SERVICES
- INTRACYTOPLASMIC SPERM INJECTION
- SEMEN FREEZING / EGG FREEZING
- IN VITRO FERTILIZATION (IVF)
- INTRAUTERINE INSEMINATION (IUI)
- SPERM DNA FRAGMENTATION TEST
- AZOOSPERMIA EVALUATION
- HSG/SSG
- CASA (SEMEN ANALYSIS)
- USG (TVS/3D)
- HORMONAL & BLOOD EVALUATION
Why Choose Us for PGD?
Personalized Approach
We offer a tailored PGD process, addressing your specific genetic concerns and customizing the treatment to your unique fertility needs.
High Success
Rate
Our use of advanced PGD technology increases the likelihood of successful implantation by selecting genetically healthy embryos, leading to better pregnancy outcomes.
Expert Genetic Counseling
Our team includes genetic counselors who help you understand the results, offering guidance on your options and ensuring you make informed decisions throughout the process.
PGD in Gender Selection
- PGD analyzes embryos for genetic material, allowing the selection of embryos with the desired gender before implantation in IVF.
- It is often used for avoiding sex-linked genetic disorders or, in some cases, for personal or cultural preferences.
- Gender selection raises concerns about reinforcing gender stereotypes and contributing to gender imbalances in society, especially when used for non-medical reasons.
Many countries regulate or prohibit gender selection for non-medical purposes to ensure ethical balance and prevent societal issues related to gender preference.
Ethical Considerations in PGD
Pre-Implantation Genetic Diagnosis (PGD) raises ethical concerns, particularly regarding embryo selection, as it allows for the potential creation of “designer babies” by selecting non-medical traits like gender or intelligence. While initially developed to prevent genetic diseases, the broader use of PGD raises moral questions about genetic engineering and societal impact.
Additionally, the process of selecting embryos for implantation and discarding others raises concerns about the value of life and the moral status of embryos. PGD also highlights issues of accessibility, as its high cost may lead to inequity in fertility treatments. As PGD advances, society must balance the benefits of eliminating genetic disorders with the ethical implications of genetic manipulation and its potential social consequences.
PGD Success Rate
Pre-Implantation Genetic Diagnosis (PGD) improves IVF success rates by selecting healthy embryos, reducing the risk of inherited genetic disorders. It enhances pregnancy chances by screening for conditions like cystic fibrosis and down syndrome. PGD is particularly effective for women under 35, increasing implantation success and reducing miscarriage rates by ensuring only genetically healthy embryos are transferred.